EXAS logo

Exact Sciences Corporation (EXAS) EBITDA

annual EBITDA:

$23.07M+$99.43M(+130.21%)
December 31, 2024

Summary

  • As of today (August 22, 2025), EXAS annual EBITDA is $23.07 million, with the most recent change of +$99.43 million (+130.21%) on December 31, 2024.
  • During the last 3 years, EXAS annual EBITDA has risen by +$546.11 million (+104.41%).
  • EXAS annual EBITDA is now at all-time high.

Performance

EXAS EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEXASincome statement metrics

quarterly EBITDA:

$58.05M+$102.03M(+231.97%)
June 30, 2025

Summary

  • As of today (August 22, 2025), EXAS quarterly EBITDA is $58.05 million, with the most recent change of +$102.03 million (+231.97%) on June 30, 2025.
  • Over the past year, EXAS quarterly EBITDA has increased by +$26.95 million (+86.68%).
  • EXAS quarterly EBITDA is now at all-time high.

Performance

EXAS quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEXASincome statement metrics

TTM EBITDA:

$51.09M+$26.95M(+111.66%)
June 30, 2025

Summary

  • As of today (August 22, 2025), EXAS TTM EBITDA is $51.09 million, with the most recent change of +$26.95 million (+111.66%) on June 30, 2025.
  • Over the past year, EXAS TTM EBITDA has increased by +$111.67 million (+184.34%).
  • EXAS TTM EBITDA is now at all-time high.

Performance

EXAS TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEXASincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

EXAS EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+130.2%+86.7%+184.3%
3 y3 years+104.4%+187.8%+110.8%
5 y5 years+120.0%+225.9%+140.8%

EXAS EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+104.4%at high+184.1%at high+110.8%
5 y5-yearat high+104.4%at high+124.1%at high+109.0%
alltimeall timeat high+104.4%at high+124.1%at high+109.0%

EXAS EBITDA History

DateAnnualQuarterlyTTM
Jun 2025
-
$58.05M(-232.0%)
$51.09M(+111.7%)
Mar 2025
-
-$43.98M(-486.7%)
$24.14M(+66.6%)
Dec 2024
$23.07M(-130.2%)
$11.37M(-55.7%)
$14.48M(-166.0%)
Sep 2024
-
$25.66M(-17.5%)
-$21.95M(-63.8%)
Jun 2024
-
$31.09M(-158.0%)
-$60.58M(-45.2%)
Mar 2024
-
-$53.64M(+114.0%)
-$110.64M(+42.8%)
Dec 2023
-$76.36M(-80.7%)
-$25.06M(+93.2%)
-$77.47M(-31.6%)
Sep 2023
-
-$12.97M(-31.6%)
-$113.19M(-33.1%)
Jun 2023
-
-$18.97M(-7.4%)
-$169.25M(-21.8%)
Mar 2023
-
-$20.47M(-66.3%)
-$216.40M(-37.2%)
Dec 2022
-$394.72M(-24.5%)
-$60.78M(-11.9%)
-$344.58M(-24.2%)
Sep 2022
-
-$69.03M(+4.4%)
-$454.58M(-3.9%)
Jun 2022
-
-$66.12M(-55.5%)
-$472.83M(-1.0%)
Mar 2022
-
-$148.66M(-13.0%)
-$477.45M(-16.2%)
Dec 2021
-$523.04M(-2511.8%)
-$170.77M(+95.7%)
-$569.60M(+59.7%)
Sep 2021
-
-$87.28M(+23.4%)
-$356.74M(+65.3%)
Jun 2021
-
-$70.74M(-70.6%)
-$215.82M(+12.9%)
Mar 2021
-
-$240.80M(-672.2%)
-$191.19M(-2023.2%)
Dec 2020
$21.69M(-118.8%)
$42.09M(-21.5%)
$9.94M(-121.7%)
Sep 2020
-
$53.64M(-216.3%)
-$45.77M(-63.4%)
Jun 2020
-
-$46.11M(+16.2%)
-$125.06M(+20.2%)
Mar 2020
-
-$39.67M(+191.1%)
-$104.08M(-16.4%)
Dec 2019
-$115.31M(-15.5%)
-$13.63M(-46.9%)
-$124.47M(-18.8%)
Sep 2019
-
-$25.65M(+2.0%)
-$153.27M(-5.6%)
Jun 2019
-
-$25.14M(-58.1%)
-$162.39M(-1.5%)
Mar 2019
-
-$60.06M(+41.6%)
-$164.81M(+20.8%)
Dec 2018
-$136.39M(+32.7%)
-$42.43M(+22.0%)
-$136.39M(+21.1%)
Sep 2018
-
-$34.77M(+26.1%)
-$112.64M(+10.2%)
Jun 2018
-
-$27.56M(-12.9%)
-$102.22M(-0.1%)
Mar 2018
-
-$31.64M(+69.3%)
-$102.33M(-0.5%)
Dec 2017
-$102.75M(-34.8%)
-$18.68M(-23.2%)
-$102.89M(-13.4%)
Sep 2017
-
-$24.34M(-12.0%)
-$118.84M(-8.4%)
Jun 2017
-
-$27.67M(-14.1%)
-$129.74M(-10.1%)
Mar 2017
-
-$32.19M(-7.1%)
-$144.34M(-8.4%)
Dec 2016
-$157.51M(+4.1%)
-$34.64M(-1.7%)
-$157.51M(-2.2%)
Sep 2016
-
-$35.24M(-16.6%)
-$161.10M(-3.6%)
Jun 2016
-
-$42.27M(-6.8%)
-$167.20M(+2.9%)
Mar 2016
-
-$45.36M(+18.6%)
-$162.50M(+7.2%)
Dec 2015
-$151.32M(+56.3%)
-$38.23M(-7.5%)
-$151.57M(+4.9%)
Sep 2015
-
-$41.34M(+10.0%)
-$144.47M(+7.5%)
Jun 2015
-
-$37.58M(+9.2%)
-$134.43M(+16.2%)
Mar 2015
-
-$34.42M(+10.6%)
-$115.73M(+19.5%)
Dec 2014
-$96.83M(+113.5%)
-$31.14M(-0.5%)
-$96.83M(+24.9%)
Sep 2014
-
-$31.29M(+65.7%)
-$77.52M(+35.6%)
Jun 2014
-
-$18.88M(+21.6%)
-$57.15M(+13.6%)
Mar 2014
-
-$15.52M(+31.3%)
-$50.28M(+10.9%)
Dec 2013
-$45.34M(-12.2%)
-$11.82M(+8.3%)
-$45.34M(-4.0%)
Sep 2013
-
-$10.92M(-9.2%)
-$47.24M(-3.8%)
Jun 2013
-
-$12.02M(+13.6%)
-$49.08M(-5.1%)
Mar 2013
-
-$10.58M(-22.9%)
-$51.74M(+0.2%)
Dec 2012
-$51.66M
-$13.72M(+7.6%)
-$51.66M(+22.4%)
Sep 2012
-
-$12.76M(-13.1%)
-$42.20M(+13.5%)
DateAnnualQuarterlyTTM
Jun 2012
-
-$14.68M(+39.8%)
-$37.16M(+27.9%)
Mar 2012
-
-$10.50M(+146.2%)
-$29.05M(+26.9%)
Dec 2011
-$28.42M(+145.1%)
-$4.26M(-44.8%)
-$22.89M(+2.3%)
Sep 2011
-
-$7.73M(+17.7%)
-$22.39M(+24.4%)
Jun 2011
-
-$6.56M(+51.4%)
-$17.99M(+29.9%)
Mar 2011
-
-$4.33M(+15.3%)
-$13.86M(+19.5%)
Dec 2010
-$11.60M(+40.1%)
-$3.76M(+12.8%)
-$11.60M(+20.6%)
Sep 2010
-
-$3.33M(+37.4%)
-$9.62M(+31.0%)
Jun 2010
-
-$2.43M(+17.0%)
-$7.34M(-0.0%)
Mar 2010
-
-$2.08M(+16.6%)
-$7.34M(-18.7%)
Dec 2009
-$8.28M(-5.4%)
-$1.78M(+68.2%)
-$9.04M(-1.5%)
Sep 2009
-
-$1.06M(-56.4%)
-$9.17M(-13.2%)
Jun 2009
-
-$2.43M(-35.6%)
-$10.56M(+6.0%)
Mar 2009
-
-$3.77M(+96.8%)
-$9.96M(+13.9%)
Dec 2008
-$8.74M(-20.9%)
-$1.92M(-21.8%)
-$8.74M(-17.4%)
Sep 2008
-
-$2.45M(+33.7%)
-$10.58M(-8.6%)
Jun 2008
-
-$1.83M(-28.2%)
-$11.58M(-1.0%)
Mar 2008
-
-$2.55M(-32.0%)
-$11.69M(+5.7%)
Dec 2007
-$11.06M(-11.2%)
-$3.75M(+9.1%)
-$11.06M(+21.0%)
Sep 2007
-
-$3.44M(+77.1%)
-$9.14M(+5.2%)
Jun 2007
-
-$1.94M(+1.3%)
-$8.69M(-12.3%)
Mar 2007
-
-$1.92M(+4.5%)
-$9.90M(-18.3%)
Dec 2006
-$12.45M(-9.1%)
-$1.84M(-38.5%)
-$12.13M(-6.1%)
Sep 2006
-
-$2.99M(-5.5%)
-$12.91M(-1.2%)
Jun 2006
-
-$3.16M(-23.7%)
-$13.06M(-5.1%)
Mar 2006
-
-$4.14M(+58.1%)
-$13.76M(+2.1%)
Dec 2005
-$13.70M(-21.6%)
-$2.62M(-16.6%)
-$13.48M(-11.3%)
Sep 2005
-
-$3.14M(-18.6%)
-$15.19M(-6.3%)
Jun 2005
-
-$3.86M(+0.0%)
-$16.20M(-1.1%)
Mar 2005
-
-$3.86M(-10.9%)
-$16.38M(-6.2%)
Dec 2004
-$17.47M(-32.9%)
-$4.33M(+4.0%)
-$17.47M(-4.8%)
Sep 2004
-
-$4.16M(+3.0%)
-$18.34M(-9.6%)
Jun 2004
-
-$4.04M(-18.3%)
-$20.29M(-13.7%)
Mar 2004
-
-$4.94M(-5.0%)
-$23.50M(-9.7%)
Dec 2003
-$26.03M(-9.3%)
-$5.20M(-14.9%)
-$26.03M(-4.9%)
Sep 2003
-
-$6.11M(-15.7%)
-$27.38M(-3.4%)
Jun 2003
-
-$7.25M(-2.9%)
-$28.34M(-1.4%)
Mar 2003
-
-$7.46M(+13.9%)
-$28.74M(+0.2%)
Dec 2002
-$28.69M(+14.4%)
-$6.55M(-7.4%)
-$28.69M(+0.9%)
Sep 2002
-
-$7.07M(-7.5%)
-$28.44M(+3.8%)
Jun 2002
-
-$7.65M(+3.2%)
-$27.39M(+5.2%)
Mar 2002
-
-$7.41M(+17.6%)
-$26.04M(+5.8%)
Dec 2001
-$25.08M(+94.0%)
-$6.30M(+4.5%)
-$24.62M(+3.6%)
Sep 2001
-
-$6.03M(-4.3%)
-$23.76M(+34.0%)
Jun 2001
-
-$6.30M(+5.2%)
-$17.73M(+55.1%)
Mar 2001
-
-$5.99M(+10.0%)
-$11.43M(+114.0%)
Dec 2000
-$12.93M(+167.1%)
-
-
Dec 2000
-
-$5.44M(-5506.0%)
-$5.34M(-5406.0%)
Mar 2000
-
$100.70K
$100.70K
Dec 1999
-$4.84M(+28.1%)
-
-
Dec 1998
-$3.78M(+96.5%)
-
-
Dec 1997
-$1.92M
-
-

FAQ

  • What is Exact Sciences Corporation annual EBITDA?
  • What is the all time high annual EBITDA for Exact Sciences Corporation?
  • What is Exact Sciences Corporation annual EBITDA year-on-year change?
  • What is Exact Sciences Corporation quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Exact Sciences Corporation?
  • What is Exact Sciences Corporation quarterly EBITDA year-on-year change?
  • What is Exact Sciences Corporation TTM EBITDA?
  • What is the all time high TTM EBITDA for Exact Sciences Corporation?
  • What is Exact Sciences Corporation TTM EBITDA year-on-year change?

What is Exact Sciences Corporation annual EBITDA?

The current annual EBITDA of EXAS is $23.07M

What is the all time high annual EBITDA for Exact Sciences Corporation?

Exact Sciences Corporation all-time high annual EBITDA is $23.07M

What is Exact Sciences Corporation annual EBITDA year-on-year change?

Over the past year, EXAS annual EBITDA has changed by +$99.43M (+130.21%)

What is Exact Sciences Corporation quarterly EBITDA?

The current quarterly EBITDA of EXAS is $58.05M

What is the all time high quarterly EBITDA for Exact Sciences Corporation?

Exact Sciences Corporation all-time high quarterly EBITDA is $58.05M

What is Exact Sciences Corporation quarterly EBITDA year-on-year change?

Over the past year, EXAS quarterly EBITDA has changed by +$26.95M (+86.68%)

What is Exact Sciences Corporation TTM EBITDA?

The current TTM EBITDA of EXAS is $51.09M

What is the all time high TTM EBITDA for Exact Sciences Corporation?

Exact Sciences Corporation all-time high TTM EBITDA is $51.09M

What is Exact Sciences Corporation TTM EBITDA year-on-year change?

Over the past year, EXAS TTM EBITDA has changed by +$111.67M (+184.34%)
On this page